mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.3 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
Cyclopamine |
GDSC1000 |
pan-cancer |
AAC |
0.055 |
0.3 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.3 |
mRNA |
KIN001-270 |
GDSC1000 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.3 |
mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |